CD274 and glioblastoma: Interestingly, membranous PD-L1 expression was observed in 37.6–61% of human glioblastoma samples, while diffuse/fibrillary PD-L1 expression was seen in 88.0% of patients, indicating that the target is present in the majority of patients [7, 8].